Nanologica AB (publ) (NICA.ST) Research

Founded in Södertälje, Sweden, in 2004, Nanologica AB (publ) is a nanotechnology company dedicated to creating nanoporous silica. This specialized material finds critical applications within the life science industry, particularly in drug development and chromatography separation. The firm's comprehensive product line features the NLAB Silica platform for advanced drug delivery, the NLAB Spiro inhalation platform targeting pulmonary administration, SVEA (U)HPLC analytical columns, and systems for preparative chromatography.

Market snapshot

Symbol
NICA.ST
Price
$0.57
Day change
-1.38%
Market cap
$52.9M
P/E ratio
2.12x
52-week range
0.33-2.25
Sector
Healthcare
Industry
Biotechnology
Next earnings
in 2 months

Peer companies

  • Active Biotech AB (publ) (ACTI.ST)
  • Biosergen AB (BIOSGN.ST)
  • Biovica International AB (publ) (BIOVIC-B.ST)
  • Scandinavian ChemoTech AB (publ) (CMOTEC-B.ST)
  • NextCell Pharma AB (NXTCL.ST)
  • Pila Pharma AB (publ) (PILA.ST)
  • Spago Nanomedical AB (publ) (SPAGO.ST)
  • Sprint Bioscience AB (publ) (SPRINT.ST)

Open Nanologica AB (publ) (NICA.ST) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.